TAAV
Leading player in the production of synthetic DNA used in gene therapy.
Touchlight Adeno Asociated Virus manufactures advanced gene therapy solutions by offering its synthetic, linear, double-stranded DNA as the new industry standard for transfection-based adeno-associated virus (AAV) production. A safer, more efficient, scalable and faster way to manufacture AAVs.
CEO: Alfredo Martínez.
DIVESTED COMPANY
2018-2019 (Sold to Askbio)
Details
TAAV
Parque Científico y Tecnológico de Gipuzkoa
Paseo Mikeletegi, 73 B.
20009 – San Sebastián (Gipuzkoa)